Stock Earnings

Question 1

Axsome Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Axsome Therapeutics Inc 的总资产为 $568，净loss为 $-287

Question 2

AXSM 的关键财务比率是什么？

Accepted Answer

Axsome Therapeutics Inc 的流动比率是 1.11，净利 margin 为 -74.54，每股销售为 $8.03。

Question 3

Axsome Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Axsome Therapeutics Inc largest revenue segment is Novel Therapies for the Management of Central Nervous System Disorders, at a revenue of 385,693,000 in the most earnings release.For geography, United States is the primary market for Axsome Therapeutics Inc, at a revenue of 378,159,000.

Question 4

Axsome Therapeutics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Axsome Therapeutics Inc 的净loss为 $-287

Question 5

Axsome Therapeutics Inc 有负债吗？

Accepted Answer

yes，Axsome Therapeutics Inc 的负债为 511

Question 6

Axsome Therapeutics Inc 的流通股有多少？

Accepted Answer

Axsome Therapeutics Inc 的总流通股为 49

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	495	385	270	50	0	0
Revenue Growth (YoY)	70%	43%	440%	--	--	--
Cost of Revenue	42	33	26	5	--	--
Gross Profit	452	352	244	44	--	--
Selling, General & Admin	462	411	323	158	66	28
Research & Development	194	187	97	57	58	70
Operating Expenses	684	632	476	224	124	99
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-247	-287	-238	-187	-130	-102
Income Tax Expense	0	0	0	--	--	--
Net Income	-246	-287	-239	-187	-130	-102
Net Income Growth	-20%	20%	28%	44%	27%	50%
Shares Outstanding (Diluted)	49.44	47.91	45.42	40.66	37.62	37.21
Shares Change (YoY)	4%	5%	12%	8%	1%	9%
EPS (Diluted)	-4.99	-5.99	-5.26	-4.6	-3.47	-2.77
EPS Growth	-23%	14%	14%	33%	25%	38%
Free Cash Flow	-121	-128	-145	-117	-108	-78
Free Cash Flow Per Share	-2.44	-2.67	-3.19	-2.87	-2.87	-2.09
Gross Margin	91.31%	91.42%	90.37%	88%	--	--
Operating Margin	-46.66%	-72.72%	-85.55%	-358%	0%	0%
Profit Margin	-49.69%	-74.54%	-88.51%	-374%	0%	0%
Free Cash Flow Margin	-24.44%	-33.24%	-53.7%	-234%	0%	0%
EBITDA	-223	-273	-225	-175	-124	-99
EBITDA Margin	-45.05%	-70.9%	-83.33%	-350%	0%	0%
D&A For EBITDA	8	7	6	4	0	0
EBIT	-231	-280	-231	-179	-124	-99
EBIT Margin	-46.66%	-72.72%	-85.55%	-358%	0%	0%
Effective Tax Rate	0%	0%	0%	--	--	--

Axsome Therapeutics Inc (AXSM) Price

AXSM Stock Price Chart

AXSM Income

Follow-Up Questions